Singapore — Through a 12-month partnership between Watsons and Cardiatrics, cardiovascular disease (CVD) prevention specialist, customers now have easier access to clinical preventive care via Cardiatrics’ unique personalised treatment products through all Watsons Pharmacists (about 40) across Singapore.

Cardiatrics products are geared towards the early detection of an individual’s risk of cardiovascular disease followed by a clinical personalised treatment to tackle the risk factors of CVD, namely high blood pressure (hypertension), high cholesterol, high blood glucose (pre-diabetes and diabetes) and high Body Mass Index (obesity).

Watsons and Cardiatrics established this partnership to offer a medically-driven preventive personalised treatment through the network of Watsons pharmacists. This strategic move is part of Watsons’ focus to bring an integrated range of offerings that provide both preventative care and disease management to its customers.

Watsons’ pharmacists will now not only offer traditional over-the-counter products, but also clinically based lifestyle intervention solutions in collaboration with doctors and other allied health professionals. The aim is to make clinically based medical lifestyle therapies easily accessible to all through Watsons’ wide retail network.

“Preventive and lifestyle medical offerings will play a bigger role in healthcare, especially in the Singapore setting where we enjoy one of the highest life expectancy in the world. This is also why Watsons is evolving its role in the area of community health with a holistic health care approach, “said Irene Lau, Chief Operating Officer, Watsons Singapore.